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ABSTRACT
Purpose: We aimed to estimate the prevalence of trachomatous inflammation—follicular (TF) in
children aged 1–9 years, trichiasis in adults aged ≥15 years, and water and sanitation (WASH)
indicators in 12 suspected-endemic districts in Uganda.
Methods: Surveys were undertaken in 14 evaluation units (EUs) covering 12 districts. Districts were
selected based on a desk review in 2014 (four districts) and trachoma rapid assessments in 2018
(eight districts). We calculated that 1,019 children aged 1–9 years were needed in each EU to
estimate TF prevalence with acceptable precision and used three-stage cluster sampling to select
30 households in each of 28 (2014 surveys) or 24 (2018 surveys) villages. Participants living in
selected households aged ≥1 year were examined for trachoma; thus enabling estimation of
prevalences of TF in 1–9 year-olds and trichiasis in ≥15 year-olds. Household-level WASH access
data were also collected.
Results: A total of 11,796 households were surveyed; 22,465 children aged 1–9 years and 24,652
people aged ≥15 years were examined. EU-level prevalence of TF ranged from 0.3% (95%
confidence interval [CI] 0.1–0.7) to 3.9% (95% CI 2.1–5.8). EU-level trichiasis prevalence ranged
from 0.01% (95% CI 0–0.11) to 0.81% (95% CI 0.35–1.50). Overall proportions of households with
improved drinking water source, water source in yard or within 1km, and improved sanitation
facilities were 88.1%, 23.0% and 23.9%, respectively.
Conclusion: TF was not a public health problem in any of the 14 EUs surveyed: antibiotic mass
drug administration is not required in these districts. However, in four EUs, trichiasis prevalence
was ≥ 0.2%, so public health-level trichiasis surgery interventions are warranted. These findings
will facilitate planning for elimination of trachoma in Uganda.
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Background
Trachoma, a neglected tropical disease, is the most
common infectious cause of blindness. Elimination of
trachoma as a public health problem (through the sur-
gery, antibiotics, facial cleanliness and environmental
improvement: “SAFE” strategy”) is a global initiative
that was endorsed by the World Health Assembly in
1998.1,2 The World Health Organization (WHO) esti-
mated that in 2016: 190.2 million people worldwide
required the A, F and E components of SAFE for the
purposes of trachoma elimination3; 1.9 million people
were blind or visually impaired from the disease; and
3.2 million people needed surgery to avoid trachoma-
tous blindness.4
Trachoma is endemic in Uganda. A review con-
ducted in 1934 reported that tens of thousands of
individuals with conjunctivitis and trachoma were pre-
senting to the eye clinic at Mulago Hospital, Kampala.5
Other evidence from the 1960s (Busoga district) and
1970s (Bukedi district) suggested that trachoma was
likely to be endemic throughout the country and was
the leading cause of blindness there.6–9
Prior to SAFE implementation, baseline surveys of
trachoma prevalence are recommended to guide pro-
grammes to deliver appropriate interventions.10 To
enable planning for implementation of the SAFE strat-
egy, baseline population-based prevalence surveys
(PBPS) of trachoma were conducted from 2006–2012
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in districts of Uganda suspected to be endemic.
Implementation of the SAFE strategy commenced in
2007 with gradual scale-up of interventions to cover, by
2014, all 38 districts confirmed to be endemic.
To consolidate SAFE implementation, in 2014 the
Ministry of Health and partners launched a Trachoma
Action Plan (TAP) that set the national elimination
target as 2020,11 in line with the international goal.1
The TAP identified a total of 19 districts bordering
known trachoma-endemic districts (based on
2006–2012 PBPS data). Following the criteria for
where to map and where not to map used by the
Global Trachoma Mapping Project,12 the TAP recom-
mended that additional baseline surveys of these dis-
tricts be undertaken. This paper describes the methods
and results of 14 such surveys undertaken in 12
unmapped districts (four completed in 2014 and eight
in 2018). The surveys reported here aimed to estimate
the prevalence of TF, trichiasis and key water, sanita-
tion, and hygiene (WASH) indicators.
Materials and methods
The Ministry of Health conducted PBPS using the
standardised WHO-recommended methodology13
with the support of the Global Trachoma Mapping
Project (GTMP)14 for the 2014 surveys, and Tropical
Data15 (https://www.tropicaldata.org/) for the 2018 sur-
veys. Fieldwork training was conducted using version 1
of the GTMP training system in 201416 and refresher
training undertaken using Tropical Data methods in
2018.17 Unlike the surveys supported by GTMP version
1, those using Tropical Data included examination for
trachomatous conjunctival scarring (TS) and questions
on previous trichiasis management recommendations
from health workers, for all eyes diagnosed to have
trichiasis, as recommended by a November 2015
Global Scientific Meeting.18
Study settings
Figure 1 shows the districts in which surveys were under-
taken. The four districts surveyed in 2014 were selected
following a health facility-based desk-review that covered
eight districts of the Teso sub-region. Based on the desk
review, districts were prioritised for mapping if: 1) more
than 10 cases of trichiasis had been reported per year, for
two or more years in the period 2008–2012; 2) more than
40% of the health staff interviewed identified trichiasis as
a problem in their catchment area; and 3) the district
bordered a district in which the prevalence of TF in
1–9 year-olds was >10%. In 2017, trachoma rapid
Figure 1. Uganda districts surveyed for trachoma from 2006–2012, considered as part of the desk reviews and trachoma rapid
assessments described herein (A), and/or surveyed in 2014 or 2018 (B).
TF, trachomatous inflammation—follicular; TRA, trachoma rapid assessment
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assessments (TRAs)19 were undertaken in 19 districts.
Eight districts in which TRA findings suggested that
trachoma might be a public health problem (proportion
of children aged 1–9 years with TF≥5% and/or propor-
tion of people aged ≥15 years with trichiasis ≥1%) were
prioritised for PBPS. To conform to WHO
recommendations,20 two districts (Arua and Hoima)
with populations > 500,000 were each split into two
evaluation units (EUs), whereas other districts were sur-
veyed as single EUs. This created a total of 14 EUs, four
of which were surveyed in 2014, and 10 in 2018.
Sample size estimation
To estimate the district-level prevalence of TF among
children aged 1–9 years, the sample size was calculated
to allow 95% confidence of estimating an expected
prevalence of 10% with absolute precision of ± 3%,
using a design effect of 2.65 and inflated by a factor
of 1.2 to account for non-response.13 We therefore
wanted to sample at least the number of households
in which 1,222 children aged 1–9 years would be resi-
dent, in each EU, hoping to examine 1,019. For the
2014 surveys, because the mean number of children
aged 1–9 years per household was estimated to be 1.5
(from DHS 2011)21 and estimating that a survey team
could complete 30 households within a day, a total of
28 clusters (villages) were required for each EU. One of
the lessons from the 2014 surveys was that the mean
number of children aged 1–9 years per household was
higher, at 1.7. This lesson was applied to the 2018
survey and the number of clusters per EU was reduced
to 24; the cluster size of 30 households was maintained.
Sample selection
A multi-stage cluster sampling design was used.
Selection of clusters
For each EU, the list of parishes (the second lowest
administrative level, mean population 5,000) and their
population estimates were obtained from the Uganda
Bureau of Statistics. In the first sampling stage, parishes
(28 in 2014 and 24 in 2018) were systematically selected
with probability proportional to population size. Within
selected parishes, the list of villages was obtained from the
district authorities and for the second sampling stage, one
village was selected randomly using the lottery method.
Selection of households and individuals
A household was defined as persons living together and
sharing meals from the same cooking pot. In the third
sampling stage, 30 households per village were selected
using the compact segment sampling method and all
household members aged one year and above were
examined for trachoma.
Training of survey teams
Initial training in 2014 was undertaken over 4 days using
the GTMP training system.16 The same grader/recorder
teams participated in 2018 surveys; prior to that work,
a specifically designed two-day refresher team training
course was undertaken using Tropical Data methods.17
Trainings were facilitated by GTMP/Tropical Data-
certified grader and recorder trainers. For graders, inter-
grader agreement tests were conducted using sets of 50
subjects. Only graders achieving a kappa of at least 0.7 for
TF, compared to a certified grader trainer, were eligible
to participate in the surveys. Survey recorders were
trained on household interviews and electronic capture
of survey data using the GTMP (2014) and Tropical Data
(2018) systems. Graders and recorders had to pass their
respective tests at each training point to qualify to con-
tribute to the following surveys. Once grader and recor-
der training was completed, participants who qualified
were paired into teams for further team training.
Household interviews
Household interviews on WASH were undertaken by
recorders using a standard questionnaire.13 Heads of
households (or another adult, if the head of household
was absent or unable to respond for any reason) were
interviewed about types of water sources, distance to
water source and type of sanitation facilities used by the
household; when the family reported using a latrine,
the type of latrine was verified through observation.
Trachoma grading
The eyelid and tarsal conjunctiva of each eye were
examined using a 2.5× magnifying loupe and torch or
daylight, looking for signs of trichiasis and TF.
Following successful piloting in Viet Nam22 and
Pakistan,23 for the Uganda surveys conducted in 2018
(but not in 2014), the tarsal conjunctiva of eyes with
trichiasis was examined for TS, and individuals were
asked about previous trichiasis management recom-
mendations from health workers.
Data management and analysis
Data were collected electronically using Android smart-
phones loaded with purpose-built apps developed for the
GTMP (2014) or Tropical Data (2018). Descriptive
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statistics were generated to examine sample characteristics
and EU-level proportions of households with key WASH
indicators. WASH data were categorised based on WHO/
UNICEF Joint Monitoring Program (JMP) definitions for
improved and unimproved water sources and sanitation
facilities (https://www.wssinfo.org/definitions-methods
/watsan-categories/). Prevalence estimates and 95% con-
fidence intervals (CIs) for TF and trichiasis were generated
using GTMP methods in R (R Foundation for Statistical
Computing, Vienna, Austria) and Structured Query
Language. For each cluster, the proportion of 1–9 year-
olds with TF was adjusted for age in one-year age bands,
using data from themost recent (2014) census.24 Similarly,
for each cluster, the proportion of ≥15 year-olds with
trichiasis was adjusted for gender and age in five-year
age bands.13 EU-level prevalences of TF and trichiasis
were calculated as the means of the adjusted cluster-level
proportions, and CIs for each were calculated by boot-
strapping, with replacement, sets of n observations (where
n was the number of clusters in the EU) over 10,000
replications and taking the 2.5th and 97.5th centiles of
ordered results as the lower and upper CI bounds.
Ethical considerations
Ethical approval was granted by the ethics commit-
tee of the London School of Hygiene & Tropical
Medicine, London, UK (reference numbers 6319
and 8355) and the Biomedical Ethics Board of
Uganda. We obtained informed verbal consent for
examination from each participant or (for children)
from their parent or guardian. Individuals with con-
junctivitis, whether meeting the definition of active
trachoma (TF and/or trachomatous inflammation—
intense [TI]) or not, were provided with two tubes
of 1% tetracycline eye ointment, while individuals
with trichiasis were referred to a district hospital
surgeon.
Results
Characteristics of survey population
Table 1 summarises the characteristics of the popula-
tion by EU. A total of 47,117 participants aged
1–9 years and ≥15 years (93.8% of those enumerated)
were examined. The proportions of male participants
among children aged 1–9 years and people aged
≥15 years were 50.4% and 38.8%, respectively. The
mean ages (standard deviations) of examinees aged
1–9 years and ≥15 years were 4.8 years (2.5) and
35.7 years (16.8), respectively. Ta
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Prevalence of trachoma
A total of 22,465 children aged 1–9 years and 24,652
people aged ≥15 years were examined for TF and tri-
chiasis, respectively. Prevalence of TF by EU ranged
from 0.3% (95% CI 0.1–0.7) in Buikwe to 3.9% (95%
CI 2.1–5.8) in Katakwi. Among people aged ≥ 15 years,
prevalence of any trichiasis by EU ranged from 0.04%
(95% CI 0.0–0.11) in Katakwi to 0.81% (95% CI
0.35–1.50) in Arua 2 (Table 2 and Figure 2). For 2018
surveys, in addition to calculating the prevalence of any
trichiasis for each EU, we were able to determine EU-
level prevalence estimates of trichiasis in which TS was
also present in the same eye (trichiasis+TS) and the
existence of that state was unknown to the health
system.25 Of the 10 EUs with these data, the prevalence
of trichiasis+TS unknown to the health system was
≥0.2% in three (Table 2).
Prevalence of access to water and sanitation
Table 3 summarises key indicators of access to WASH.
The overall proportion of households that reported:
using an improved drinking water source was 88%
(range by EU 76–99); having a drinking water source
in the household yard or within 1km of it was 23%
(range by EU 4–41); and having access to improved
sanitation facilities was 24% (range by EU 10–61).
Discussion
Over the last decade, Uganda has made tremendous
progress towards trachoma elimination, with 34 of 38
eligible endemic districts having stopped azithromycin
mass drug administration (MDA) by December 2017.
With the national 2020 elimination target11 fast
approaching, data from baseline surveys in suspected
endemic districts are critical for planning SAFE inter-
ventions. The data presented here show that TF was
below <5% in all 14 EUs surveyed, indicating that
antibiotic MDA will not be required. However, four
EUs had trichiasis prevalences of ≥0.2%, suggesting
a requirement for public health-level trichiasis surgery
programmes. Further trichiasis-only surveys26 will ulti-
mately be needed in those EUs to document attainment
of elimination.27
Our surveys estimated key indicators of access to
WASH, based on WHO/UNICEF JMP definitions,
and this enables comparison with Demographic and
Health Survey (DHS) findings. The 2016 Uganda DHS
reported that of surveyed rural households, 74% used
an improved source of drinking water; 45% had
a drinking water source in the yard or within 1km
distance; and 16% had access to an improved sanitation
facility28; those national-level estimates can be com-
pared to our more granular, EU-level ones (Table 3).
Our surveys were epidemiologically robust29 because
they used PBPS methods10 recommended by WHO30
for sampling of populations and examination for tra-
choma, and incorporated a suite of quality assurance
and quality control measures.12 Unlike the GTMP ver-
sion 1 template, the Tropical Data system involved
examination of individuals with trichiasis for TS and
asking them about previous trichiasis management
recommendations from health workers. These data
help the country determine whether EUs had reached
the elimination threshold for TT, which is a prevalence
of TT “unknown to the health system” – i.e., the pre-
valence of TT counting only those individuals with the
condition who have not previously been offered an
Table 2. Prevalence of trachoma by evaluation unit, Uganda, 2014 and 2018.
Adults aged ≥15 years
Region
Evaluation
Unit* Survey year
Prevalence of TF in children aged
1–9 years
% (95% CI)a
Prevalence of trichiasis
(95% CI)b
Prevalence of trichiasis+TS unknown to
health system
% (95% CI)b
Central Region Buikwe 2018 0.3 (0.1–0.7) 0.13 (0.03–0.24) 0.07 (0.01–0.14)
Central Region Kayunga 2018 1.0 (0.5–1.5) 0.26 (0.08–0.53) 0.20 (0.06–0.4)
Central Region Kyankwanzi 2018 0.9 (0.3–1.6) 0.06 (0.01–0.15) 0.06 (0–0.14)
Eastern Region Amuria 2014 1.8 (0.7–3.4) 0.04 (0–0.12) N/A
Eastern Region Bukedea 2014 3.2 (1.7–4.9) 0.19 (0.05–0.38) N/A
Eastern Region Kaberamaido 2014 3.4 (1.5–6.0) 0.34 (0.16–0.54) N/A
Eastern Region Katakwi 2014 3.9 (2.1–5.8) 0.04 (0–0.11) N/A
Eastern Region Ngora 2018 0.9 (0.5–1.5) 0.04 (0–0.12) 0.04 (0–0.12)
Eastern Region Serere 2018 1.3 (0.7–2.1) 0.07 (0–0.16) 0.07 (0–0.15)
Northern Region Arua 1 2018 1.0 (0.1–2.2) 0.38 (0.09–0.79) 0.35 (0.05–0.76)
Northern Region Arua 2 2018 1.2 (0.6–2.1) 0.81 (0.35–1.50) 0.65 (0.24–1.33)
Northern Region Maracha 2018 1.0 (0.4–1.7) 0.13 (0.00–0.27) 0.09 (0–0.19)
Western Region Hoima 1 2018 0.8 (0.3–1.6) 0.13 (0.02–0.29) 0.02 (0–0.06)
Western Region Hoima 2 2018 0.7 (0.3–1.2) 0.10 (0–0.28) 0 (0–0)
CI, confidence interval; N/A, not applicable; trichiasis+TS, trichiasis with trachomatous conjunctival scarring
*Arua and Hoima districts were each split into two evaluation units.
a adjusted for age, in one-year bands based on the National Population and Housing Census 2014
b adjusted for gender and age, in five-year bands based on the National Population and Housing Census 2014
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Figure 2. Prevalence of trachomatous inflammation—follicular (TF) in children aged 1–9 years, and any trichiasis in people aged
≥15 years, Uganda, 2006–2018.
A) TF prevalence in districts mapped in 2006–2012; B) TF prevalence in districts mapped in 2014 or 2018; C) TF prevalence combining all
data sources from 2006–2018D) Trichiasis prevalence in districts mapped in 2006–2012; E) Trichiasis prevalence in districts mapped in 2014
or 2018; F) Trichiasis prevalence combining all data sources from 2006–2018
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operation or epilation for it – of < 0.2%.20 However,
disproportionately low participation by adult males
posed a potential limitation to the precision of our
trichiasis estimates. Based on the 2014 population cen-
sus, we expected roughly equal numbers of men and
women aged ≥15 years to be enumerated during the
surveys.24 However, the number of males aged 15 years
and above that our teams examined was low compared
to the number of females in the same age group. We
observed similar absences of men in trachoma surveys
in neighbouring Tanzania31,32, and Democratic
Republic of Congo.33 This might be expected to lead
to overestimation of TT prevalence (given that TT is
generally more common in women than men).34
Standardisation of TT prevalence estimates for age
and gender will have partially corrected this bias, with-
out, of course, eliminating it.
The findings from these surveys suggest that TF was
not a public health problem in any of the 14 EUs that
were previously suspected to be endemic, so antibiotic
MDA is not required for trachoma elimination.
However, four EUs (Kayunga, Kaberamaido, Arua 1
and Arua 2) need to undertake public-health-level tri-
chiasis surgery interventions and trichiasis-only surveys
thereafter. These findings will facilitate planning for
elimination of trachoma in Uganda.
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